Obesity pill backed by FDA after initial rejection
Thursday, February 23, 2012 - 10:30
in Mathematics & Economics
A once rejected weight loss pill has won overwhelming endorsement from public health advisers, raising hopes the Vivus Inc. drug could become the first anti-obesity medication to reach the U.S. market in more than a decade.